News - 3 Apr 2007
The SARS epidemic, the South Asian tsunami, Hurricane Katrina, and avian influenza all underline a growing need for preparedness planning that addresses multiple hazards and coordinates all levels of...
News - 1 Apr 2020
By now, most have gotten the gist of it: Wash your hands - frequently and for at least 20 seconds. Don't touch your face. Keep a distance of at least six feet between you and other people.Stay home,...
News - 9 Nov 2015
Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced new results from its Phase 1...
News - 20 Oct 2012
Converging scientific evidence - not to mention a great deal of life experience - tells us that self-control is an important ability. It helps us keep our cool, get things done, and resist the things...
News - 11 Apr 2020
Probably few hospital systems need the emergency federal grants announced this week to handle the coronavirus crisis as badly as Florida's Jackson Health does.
News - 5 Dec 2019
Sarah Macsalka had heard the stories about how expensive an emergency room visit can be, even for a minor complaint.
News - 13 Apr 2018
A big part of Washington, D.C.’s plan to get its HIV rate down is to get more uninfected people on PrEP, a two-medicine combination pill that’s sold under the brand name Truvada.
News - 9 May 2014
Alert (or at least health-care-obsessed) readers have no doubt been following the coverage of a new study on mortality in Massachusetts in the years following Romneycare's coverage expansion.
News - 7 May 2014
ARIAD Pharmaceuticals, Inc. today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and licensing agreements. The Company also provided an...
News - 3 Apr 2012
ARIAD Pharmaceuticals, Inc. today announced the presentation of new preclinical data on its investigational pan-BCR-ABL inhibitor, ponatinib, and its investigational dual EGFR-ALK inhibitor, AP26113,...